Experts Call for Accountability in Pharma Industry Quality Control
Pharma industry leaders discuss innovations, sustainability, and the pressing need for improved quality assurance.
Chandigarh -
Emphasis on Quality and Responsibility in the Pharma Sector -
At Lindström India's Bio-Pharma Roundtable, Mr. Shyam Khante emphasized that every individual in the pharmaceutical industry, from CEOs to workers, must assume accountability for product quality. He highlighted the importance of producing medicine with the intent that it is safe enough for personal use, driving the industry's commitment to quality.
Advancements and Eco-Friendliness in Bio-Pharma Production -
The roundtable covered critical advancements in bio-pharma manufacturing, sustainability, and compliance with global standards. Speakers, including Dr. Sanjit Singh Lamba and Mr. Avtar Singh, stressed employee motivation and engagement as key to achieving "zero defects." The event also tackled pressing issues such as AI integration, workwear hygiene, and environmental contaminant management in the pharmaceutical sector.
Industry Collaboration for Global Standards -
Moderated by BioSpectrum India’s Dr. Manbeena Chawla, the session featured discussions on USFDA observations and global regulatory challenges. Manas Kumar, Lindström’s Global Director, emphasized the event’s role in shaping the future of bio-pharma by fostering collaboration and insights among industry leaders to meet global quality standards.
What's Your Reaction?
